ST PHARM

Global API CDMO Company

Walking with partners,
Creating value

Technology-driven gene therapy CDMO
from oligonucleotide to xRNA

ST PHARM NEWS

USPTO grants patent to Vernagen's mRNA-Based RSV A/B VaccineMar 11, 2025

ST PHARM 'Basroparib' Combination Therapy Preclinical Result PublishedMar 5, 2025

[Notice] ST Pharm Completes Trademark Registration for Proprietary mRNA Platform Core Technologies (SMARTCAP® & STLNP®)Mar 4, 2025

Global API CDMO Company
Walking with Partners, Creating Value

30+years

Track record

40+

Global CDMO Project

6.4mole

Oligo CDMO Capacity ('22)

1.0kg / year

mRNA CDMO Capacity

Media Focus

ST PHARM Cuts Joint Research Deal with Multiverse Pharma in the U.S.Feb 24, 2023

ST PHARM, signs $9.2million contract to supply MRI contrast medium raw materialsJan 11, 2023

IR Library

Stock Information

KRWKOSDAQ

(%)

Location

70km (43 mile)

40km (25 mile)

51km (32 mile)

Seoul Office

7F, I Park Tower Bldg., Yeongdongdae-ro 520, Gangnam-gu, Seoul
06170

Marketing and sales
Regulatory affairs
Management

Sihwa campus

231 Hyeomnyeok-ro, Siheung-si, Gyeonggi-do
15086

cGMP Manufacturing
QC/QA
R&D

Banwol campus

171 Haean-ro, Danwon-gu, Ansan-si, Gyeonggi-do
15610

cGMP Manufacturing
QC/QA
R&D

Incheon Airport

Technology-driven gene therapy CDMO from oligonucleotide to xRNA